Rishi Jain

1.4k total citations
62 papers, 685 citations indexed

About

Rishi Jain is a scholar working on Oncology, Infectious Diseases and Surgery. According to data from OpenAlex, Rishi Jain has authored 62 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Infectious Diseases and 10 papers in Surgery. Recurrent topics in Rishi Jain's work include Antimicrobial Resistance in Staphylococcus (11 papers), Nutrition and Health in Aging (6 papers) and Streptococcal Infections and Treatments (4 papers). Rishi Jain is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (11 papers), Nutrition and Health in Aging (6 papers) and Streptococcal Infections and Treatments (4 papers). Rishi Jain collaborates with scholars based in United States, India and Japan. Rishi Jain's co-authors include Jill E. Langer, Prabodh K. Gupta, Zubair Baloch, Susan J. Mandel, Virginia A. LiVolsi, Elizabeth A. Handorf, Eugene J. Fine, Howard D. Strickler, Joseph A. Sparano and Salman Motlekar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rishi Jain

59 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rishi Jain United States 15 169 157 139 106 98 62 685
Yunfei An China 17 79 0.5× 133 0.8× 96 0.7× 204 1.9× 165 1.7× 105 1.1k
George Thomson United Kingdom 14 157 0.9× 113 0.7× 103 0.7× 290 2.7× 84 0.9× 30 828
Seok Hwee Koo Singapore 16 106 0.6× 85 0.5× 119 0.9× 195 1.8× 68 0.7× 49 702
Francesco Sbrana Italy 16 266 1.6× 77 0.5× 67 0.5× 102 1.0× 159 1.6× 92 823
Alessandro Perrella Italy 18 133 0.8× 123 0.8× 106 0.8× 137 1.3× 185 1.9× 92 1.2k
Gye Cheol Kwon South Korea 14 43 0.3× 181 1.2× 62 0.4× 110 1.0× 64 0.7× 55 693
Christine L. E. Siezen Netherlands 16 136 0.8× 54 0.3× 96 0.7× 197 1.9× 98 1.0× 19 810
April Barbour United States 14 129 0.8× 123 0.8× 58 0.4× 128 1.2× 122 1.2× 30 700
Raquel Rocha Brazil 19 286 1.7× 144 0.9× 66 0.5× 189 1.8× 63 0.6× 54 1.0k
Giorgia Montrucchio Italy 18 153 0.9× 47 0.3× 55 0.4× 157 1.5× 173 1.8× 61 994

Countries citing papers authored by Rishi Jain

Since Specialization
Citations

This map shows the geographic impact of Rishi Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rishi Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rishi Jain more than expected).

Fields of papers citing papers by Rishi Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rishi Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rishi Jain. The network helps show where Rishi Jain may publish in the future.

Co-authorship network of co-authors of Rishi Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Rishi Jain. A scholar is included among the top collaborators of Rishi Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rishi Jain. Rishi Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Handorf, Elizabeth A., Igor Astsaturov, Michael J. Hall, et al.. (2024). Food Insecurity and Dietary Quality in African American Patients with Gastrointestinal Cancers: An Exploratory Study. Nutrients. 16(18). 3057–3057. 1 indexed citations
4.
Takashima, Atsuo, Pilar García‐Alfonso, Ali Ayberk Beşen, et al.. (2024). Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study. European Journal of Cancer. 205. 114036–114036. 7 indexed citations
5.
Jain, Rishi, Chethan Ramamurthy, Daohai Yu, et al.. (2023). Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors. Journal of Patient Experience. 10. 672688921–672688921. 2 indexed citations
6.
Jain, Rishi, H.J. Lenz, Wells A. Messersmith, et al.. (2021). 550P Initial results of a phase Ia/Ib study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients (pts) with advanced solid tumors. Annals of Oncology. 32. S610–S611. 4 indexed citations
7.
Handorf, Elizabeth A., et al.. (2021). Psychological distress in patients with metastatic cancer enrolling on phase I clinical trials. Journal of Cancer Survivorship. 15(3). 398–402. 5 indexed citations
8.
Mitra, Monjori, et al.. (2020). Evaluation of immunogenicity, safety and breakthrough following administration of live attenuated varicella vaccine in two doses three months apart regimen in Indian children. SHILAP Revista de lepidopterología. 8. 2672399616–2672399616. 2 indexed citations
9.
Shah, Nitin, et al.. (2020). Review of long term immunogenicity and tolerability of live hepatitis A vaccine. Human Vaccines & Immunotherapeutics. 16(11). 2816–2821. 10 indexed citations
10.
Jain, Rishi, Namrata Vijayvergia, Karthik Devarajan, et al.. (2020). Chemotherapy use and survival in older adults with metastatic pancreatic cancer in the combination therapy era. Journal of Geriatric Oncology. 11(4). 640–646. 5 indexed citations
11.
Rajput, Rajesh, et al.. (2020). Osmotic controlled drug delivery system (OSMO technology) and its impact on diabetes care. International Journal of Research in Medical Sciences. 9(1). 303–303. 1 indexed citations
12.
Bhagwat, Sachin, Parameswaran Hariharan, Ravindra Yeole, et al.. (2019). <p>Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence</p>. Drug Design Development and Therapy. Volume 13. 4351–4365. 51 indexed citations
13.
Wainberg, Zev A., Howard S. Höchster, Edward Kim, et al.. (2019). Phase I study of nivolumab (Nivo) + nab-paclitaxel (nab-P) + gemcitabine (Gem) in advanced pancreatic cancer (APC).. Journal of Clinical Oncology. 37(4_suppl). 298–298. 27 indexed citations
14.
15.
Wolfe, Adam R., Rishi Jain, Timothy M. Pawlik, Jon Walker, & Terence M. Williams. (2018). Radiation-Induced Colitis in a Pancreatic Cancer Patient With a Germline BRCA2 Mutation: A Case Report. Advances in Radiation Oncology. 4(1). 10–14. 1 indexed citations
16.
Jain, Rishi & Crystal S. Denlinger. (2017). Incorporating Weight Management into Clinical Care for Cancer Survivors: Challenges, Opportunities, and Future Directions. Obesity. 25(S2). S27–S29. 3 indexed citations
17.
Incio, João, Shan M. Chin, Raquel Soares, et al.. (2016). Proffered Paper: Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy. European Journal of Cancer. 61. S7–S8. 1 indexed citations
18.
Jain, Rishi, et al.. (2016). The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling?. Journal of the National Comprehensive Cancer Network. 14(6). 795–806. 14 indexed citations
19.
Sridharan, Ashwin, Rishi Jain, Marcus A. Bachhuber, et al.. (2014). Epidemiologic study of myelodysplastic syndromes in a multiethnic, inner city cohort. Experimental Hematology and Oncology. 3(1). 22–22. 6 indexed citations
20.
Jain, Rishi, Howard D. Strickler, Eugene J. Fine, & Joseph A. Sparano. (2013). Clinical Studies Examining the Impact of Obesity on Breast Cancer Risk and Prognosis. Journal of Mammary Gland Biology and Neoplasia. 18(3-4). 257–266. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunfei An Breakdown of academic impact, for papers by George Thomson Breakdown of academic impact, for papers by Seok Hwee Koo Breakdown of academic impact, for papers by Francesco Sbrana Breakdown of academic impact, for papers by Alessandro Perrella Breakdown of academic impact, for papers by Gye Cheol Kwon Breakdown of academic impact, for papers by Christine L. E. Siezen Breakdown of academic impact, for papers by April Barbour Breakdown of academic impact, for papers by Raquel Rocha Breakdown of academic impact, for papers by Giorgia Montrucchio
Rankless by CCL
2026